Jessica R Iyer1, Annelies Van Rie2, Sabina A Haberlen1, Mutsa Mudavanhu3, Lillian Mutunga3, Jean Bassett3, Sheree R Schwartz4. 1. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD. 2. Department of Epidemiology and Social Medicine, University of Antwerp, Antwerpen, Belgium. 3. Witkoppen Health and Welfare Centre, Fourways, Johannesburg, South Africa. 4. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD. Electronic address: sschwartz@jhu.edu.
Abstract
BACKGROUND: Subfertility among couples affected by HIV has an impact on the well-being of couples who desire to have children and may prolong HIV exposure. Subfertility in the antiretroviral therapy era and its determinants have not yet been well characterized. OBJECTIVE: The objective of the study was to investigate the burden and determinants of subfertility among HIV-affected couples seeking safer conception services in South Africa. STUDY DESIGN: Nonpregnant women and male partners in HIV seroconcordant or HIV discordant relationships desiring a child were enrolled in the Sakh'umndeni safer conception cohort at Witkoppen Clinic in Johannesburg between July 2013 and April 2017. Clients were followed up prospectively through pregnancy (if they conceived) or until 6 months of attempted conception, after which they were referred for infertility services. Subfertility was defined as not having conceived within 6 months of attempted conception. Robust Poisson regression was used to assess the association between baseline characteristics and subfertility outcomes; inverse probability weighting was used to account for missing data from women lost to safer conception care before 6 months of attempted conception. RESULTS: Among 334 couples enrolled, 65% experienced subfertility (inverse probability weighting weighted, 95% confidence interval, 0.59-0.73), of which 33% were primary subfertility and 67% secondary subfertility. Compared with HIV-negative women, HIV-positive women not on antiretroviral therapy had a 2-fold increased risk of subfertility (weighted and adjusted risk ratio, 2.00; 95% confidence interval, 1.19-3.34). Infertility risk was attenuated in women on antiretroviral therapy but remained elevated, even after ≥2 years on antiretroviral therapy (weighted and adjusted risk ratio, 1.63; 95% confidence interval, 0.98-2.69). Other factors associated with subfertility were female age (weighted and adjusted risk ratio, 1.03, 95% confidence interval, 1.01-1.05 per year), male HIV-positive status (weighted and adjusted risk ratio, 1.31; 95% confidence interval, 1.02-1.68), male smoking (weighted and adjusted risk ratio, 1.29; 95% confidence interval, 1.05-1.60), and trying to conceive for ≥1 year (weighted and adjusted risk ratio, 1.38; 95% confidence interval, 1.13-1.68). CONCLUSION: Two in 3 HIV-affected couples experienced subfertility. HIV-positive women were at increased risk of subfertility, even when on antiretroviral therapy. Both male and female HIV status were associated with subfertility. Subfertility is an underrecognized reproductive health problem in resource-limited settings and may contribute to prolonged HIV exposure and transmission within couples. Low-cost approaches for screening and treating subfertility in this population are needed.
BACKGROUND: Subfertility among couples affected by HIV has an impact on the well-being of couples who desire to have children and may prolong HIV exposure. Subfertility in the antiretroviral therapy era and its determinants have not yet been well characterized. OBJECTIVE: The objective of the study was to investigate the burden and determinants of subfertility among HIV-affected couples seeking safer conception services in South Africa. STUDY DESIGN: Nonpregnant women and male partners in HIV seroconcordant or HIV discordant relationships desiring a child were enrolled in the Sakh'umndeni safer conception cohort at Witkoppen Clinic in Johannesburg between July 2013 and April 2017. Clients were followed up prospectively through pregnancy (if they conceived) or until 6 months of attempted conception, after which they were referred for infertility services. Subfertility was defined as not having conceived within 6 months of attempted conception. Robust Poisson regression was used to assess the association between baseline characteristics and subfertility outcomes; inverse probability weighting was used to account for missing data from women lost to safer conception care before 6 months of attempted conception. RESULTS: Among 334 couples enrolled, 65% experienced subfertility (inverse probability weighting weighted, 95% confidence interval, 0.59-0.73), of which 33% were primary subfertility and 67% secondary subfertility. Compared with HIV-negative women, HIV-positive women not on antiretroviral therapy had a 2-fold increased risk of subfertility (weighted and adjusted risk ratio, 2.00; 95% confidence interval, 1.19-3.34). Infertility risk was attenuated in women on antiretroviral therapy but remained elevated, even after ≥2 years on antiretroviral therapy (weighted and adjusted risk ratio, 1.63; 95% confidence interval, 0.98-2.69). Other factors associated with subfertility were female age (weighted and adjusted risk ratio, 1.03, 95% confidence interval, 1.01-1.05 per year), male HIV-positive status (weighted and adjusted risk ratio, 1.31; 95% confidence interval, 1.02-1.68), male smoking (weighted and adjusted risk ratio, 1.29; 95% confidence interval, 1.05-1.60), and trying to conceive for ≥1 year (weighted and adjusted risk ratio, 1.38; 95% confidence interval, 1.13-1.68). CONCLUSION: Two in 3 HIV-affected couples experienced subfertility. HIV-positive women were at increased risk of subfertility, even when on antiretroviral therapy. Both male and female HIV status were associated with subfertility. Subfertility is an underrecognized reproductive health problem in resource-limited settings and may contribute to prolonged HIV exposure and transmission within couples. Low-cost approaches for screening and treating subfertility in this population are needed.
Authors: Marissa Maier; Irene Andia; Nneka Emenyonu; David Guzman; Angela Kaida; Larry Pepper; Robert Hogg; David R Bangsberg Journal: AIDS Behav Date: 2008-04-04
Authors: Adrian Pilatz; Thomas Discher; Guenter Lochnit; Julia Wolf; Hans-Christian Schuppe; Christian G Schüttler; Hamid Hossain; Wolfgang Weidner; Jürgen Lohmeyer; Thorsten Diemer Journal: AIDS Date: 2014-03-27 Impact factor: 4.177
Authors: E van Leeuwen; J M Prins; S Jurriaans; K Boer; P Reiss; S Repping; F van der Veen Journal: Hum Reprod Update Date: 2006-11-11 Impact factor: 15.610
Authors: Sheree R Schwartz; Nora West; Rebecca Phofa; Nompumelelo Yende; Ian Sanne; Jean Bassett; Annelies Van Rie Journal: Int J STD AIDS Date: 2015-09-18 Impact factor: 1.359
Authors: E van Leeuwen; M Cornelissen; J W de Vries; S H Lowe; S Jurriaans; S Repping; F van der Veen Journal: Hum Reprod Date: 2004-09-09 Impact factor: 6.918
Authors: Sara Yeatman; Jeffrey W Eaton; Zosia Beckles; Lorna Benton; Simon Gregson; Basia Zaba Journal: Trop Med Int Health Date: 2016-07-22 Impact factor: 2.622
Authors: Erica M Lokken; Lisa E Manhart; John Kinuthia; James P Hughes; Clayton Jisuvei; Khamis Mwinyikai; Charles H Muller; Kishor Mandaliya; Walter Jaoko; R Scott McClelland Journal: Hum Reprod Date: 2021-04-20 Impact factor: 6.918
Authors: Anna Hachfeld; Andrew Atkinson; Alexandra Calmy; Begoña Martinez de Tejada; Barbara Hasse; Paolo Paioni; Christian R Kahlert; Noémie Boillat-Blanco; Marcel Stoeckle; Karoline Aebi-Popp Journal: HIV Med Date: 2021-09-02 Impact factor: 3.094
Authors: Agnieszka Matuszewska; Beata Nowak; Wojciech Niżański; Maria Eberhardt; Kinga Domrazek; Anna Nikodem; Benita Wiatrak; Krzysztof Zduniak; Kamil Olejnik; Anna Merwid-Ląd; Tomasz Tomkalski; Diana Jędrzejuk; Ewa Szeląg; Marzenna Podhorska-Okołów; Aleksandra Piotrowska; Izabela Jęśkowiak; Agata Heinrich; Maria Rutkowska; Wojciech Dziewiszek; Tomasz Sozański; Joanna Kwiatkowska; Paulina Jawień; Marek Bolanowski; Adam Szeląg Journal: Oxid Med Cell Longev Date: 2021-07-29 Impact factor: 6.543
Authors: Nahid Punjani; Spyridon P Basourakos; Quincy G Nang; Richard K Lee; Marc Goldstein; Joseph P Alukal; Philip S Li Journal: World J Mens Health Date: 2021-05-18 Impact factor: 5.400